Biotech news
Pharma
Alexion Pharmaceuticals is to acquire immune-system specialist Achillion for almost $1 billion dollars. 17 October 2019
Pharma
Brexit uncertainty is already having a negative impact on UK science, according to The Royal Society, the UK’s national academy of sciences. 17 October 2019
Pharma
Uncertainty surrounding the patentability of artificial intelligence (AI) and changes to patented medicine pricing in Canada were two topics discussed yesterday, October 15 at Life Sciences Patent Network Fall in San Francisco. 17 October 2019
Pharma
Belgium head-quartered pharmaceutical company UCB is to acquire Ra Pharmaceuticals for approximately $2.1 billion. 14 October 2019
Asia
Hong Kong-based Insilico Medicine has agreed an artificial intelligence breast cancer drug discovery partnership worth a potential $200 million with a Chinese pharmaceutical company. 10 October 2019
Americas
Goldfinch Bio, a US company focused on developing treatments for kidney disease, has agreed to license a cannabinoid receptor 1 antibody from Japanese pharmaceutical manufacturer Takeda. 4 October 2019
Pharma
Novartis has teamed with Microsoft to launch a new artificial intelligence innovation lab, which it says has the potential to “transform” and “reimagine” medicine. 3 October 2019
Americas
Evolve BioSystems and the University of California have jointly sued Abbott Laboratories for patent infringement over a soon-to-be-launched probiotic product. 3 October 2019
Pharma
LSIPR’s Sarah Morgan investigates the current state of play of M&A in the sector and predicts the next year of activity. 30 September 2019
Biotech
In-house counsel face daily challenges when managing and maintaining their IP portfolios. LSIPR asked two in-house counsel for the biggest challenges they face when managing and maintaining their IP portfolios. Here are the five things we learned. 30 September 2019